Document is current
Any future updates will be listed below
-
Authors
White, Brianna M.
Gunda, Venugopal
Nethi, Susheel Kumar
Natesh, Nagabhishek Sirpu
Mullis, Adam S.
Sotelo, Mariaelena Roman
North, Jeffrey
Destache, Chris
Narasimhan, Balaji
Batra, Surinder K.
Mallapragada, Surya K. https://orcid.org/0000-0002-9482-7273
Rachagani, Satyanarayana
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA247763)
- License Information
-
More Information
Article History
Received: 23 July 2024
Revised: 14 January 2025
Accepted: 24 February 2025
First Online: 17 March 2025
Declarations
:
: The experimental animal protocols were approved by the University of Nebraska Medical Center’s Institutional Animal Care and Use Committee (protocol code 20–091-11-FC). On behalf of all authors, the corresponding authors affirm that animal rights were upheld in the study.
: On behalf of all authors, the corresponding authors state that informed consent was obtained from all participants involved in the study.
: Surinder Batra is one of the co-founders of Sanguine Diagnostics and Therapeutics, Inc. In addition, Surya K Mallapragada and Balaji Narasimhan have a financial interest in ImmunoNanomed.
